Rockwell Medical (NASDAQ:RMTI) Raised to “Hold” at Zacks Research

Rockwell Medical (NASDAQ:RMTI – Get Free Report) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Thursday, Zacks reports.

Several other research firms have also recently issued reports on RMTI. Weiss Ratings raised Rockwell Medical from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, October 8th. Wall Street Zen raised Rockwell Medical to a “hold” rating in a research report on Saturday, July 25th. Finally, HC Wainwright reissued a “buy” rating and set a $20.00 target price on shares of Rockwell Medical in a research report on Friday, September 11th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Rockwell Medical presently has an average rating of “Hold” and an average target price of $20.00.

Read Our Latest Stock Report on RMTI

Rockwell Medical Stock Down 4.7%

NASDAQ:RMTI traded down $0.35 during trading hours on Thursday, hitting $7.03. The company’s stock had a trading volume of 42,451 shares, compared to its average volume of 24,348. The stock has a market capitalization of $28.33 million, a P/E ratio of -4.92 and a beta of 1.75. The stock has a fifty day moving average of $7.80 and a 200-day moving average of $8.07. The company has a current ratio of 3.25, a quick ratio of 3.00 and a debt-to-equity ratio of 0.21. Rockwell Medical has a 52-week low of $4.89 and a 52-week high of $12.90.

Rockwell Medical (NASDAQ:RMTI – Get Free Report) last posted its quarterly earnings results on Thursday, November 12th. The company reported ($0.59) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.41). The business had revenue of $19.12 million during the quarter, compared to analyst estimates of $18.22 million. Rockwell Medical had a negative net margin of 7.79% and a negative return on equity of 15.72%. On average, equities analysts forecast that Rockwell Medical will post -0.90 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Rockwell Medical stock. Corsair Capital Management L.P. bought a new stake in Rockwell Medical, Inc. (NASDAQ:RMTI – Free Report) during the first quarter, according to its most recent disclosure with the SEC. The firm bought 50,000 shares of the company’s stock, valued at approximately $45,000. Corsair Capital Management L.P. owned about 0.13% of Rockwell Medical at the end of the most recent reporting period. Institutional investors and hedge funds own 23.31% of the company’s stock.

Key Rockwell Medical News

Investors following RMTI have been watching these news items:

  • Positive Sentiment: Third-quarter sales rose 20% year over year to $19.1 million, ahead of estimates; gross profit increased 37% to $3.1 million, and gross margin improved to 16% from 14%. Rockwell Medical reports third-quarter sales
  • Positive Sentiment: The proposed acquisition of Vantive’s hemodialysis products and related business could substantially expand Rockwell Medical’s scale. Management expects the combined company to generate $400 million to $450 million in annual revenue and targets closing in mid-2027. Combined revenue outlook and Vantive closing target
  • Negative Sentiment: Regulatory approvals for the Vantive transaction could bring costly conditions and reduce expected synergies, creating uncertainty around the deal’s benefits and timeline. Regulatory risks around the Vantive transaction

Rockwell Medical Company Profile

(Get Free Report)

Rockwell Medical, Inc. is a healthcare company that develops, manufactures and distributes products used in the treatment of people with kidney disease, particularly patients receiving hemodialysis. Its offerings include acid and bicarbonate concentrates used to prepare dialysis solutions, as well as related supplies and services for dialysis providers. The company has also developed pharmaceutical products for use in dialysis care. Founded in 1996, Rockwell Medical is based in the United States and serves dialysis providers in the U.S. and select international markets.

See Also

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.